the authors suggest that cholinergic modulating drugs might improve ataxia and possibly other symptoms in patients with MSA-C or SCA3.

Drugs acting on the cholinergic system can improve or worsen cognitive abilities, and their effects are particularly pronounced in frail elderly individuals and patients with Alzheimer disease.